Wie hoch ist der Preis für Venus Medtech (Hangzhou) Inc. (2500)

Preis für Venus Medtech (Hangzhou) Inc. (2500) ist $0.13048475

Wie hoch ist die Marktkapitalisierung für Venus Medtech (Hangzhou) Inc. (2500)

Marktkapitalisierung für Venus Medtech (Hangzhou) Inc. (2500) ist $57.55M

Venus Medtech (Hangzhou) Inc. (2500) Preis und Marktkapitalisierung

Venus Medtech (Hangzhou) Inc., together with its subsidiaries, engages in the research, development, manufacturing, and sale of bioprosthetic heart valves in Mainland China and internationally. The company’s offers transcatheter aortic heart valve replacement products, such as VenusA-Valve, VenusA-Plus, VenusA-Pro, and VenusA-Deluxe; and VenusP-Valve, a transcatheter pulmonary valve system to treat the patients suffering with moderate to severe pulmonary regurgitation with or without right ventricular outflow tract stenosis. It also develops Venus-Vitae, a balloon-expandable dry-tissue product; Venus-PowerX, a self-expanding dry-tissue product; Cardiovalve, a transcatheter valve replacement system for the treatment of patients with mitral regurgitation and in pivotal clinical trial for the treatment of patients with tricuspid regurgitation; Liwen RF, a radiofrequency ablation system for the treatment of hypertrophic cardiomyopathy; and renal artery denervation ablation system for the treatment of hypertension. In addition, the company offers procedural accessories comprising catheter sheath product and balloon catheter. Venus Medtech (Hangzhou) Inc. was incorporated in 2009 and is headquartered in Hangzhou, the People’s Republic of China.

Preis für 2500	Vermögenswert B	Marktkapitalisierung von B	Ergebnisse
$11,805.40 $57.55M	NVDA	$5.206T	+9,047,243.45%
$10,280.24 $57.55M	AAPL	$4.534T	+7,878,402.39%
$9,355.99 $57.55M	GOOG	$4.126T	+7,170,077.49%
$8,136.26 $57.55M	MSFT	$3.588T	+6,235,311.01%
$6,328.59 $57.55M	AMZN	$2.791T	+4,849,960.26%

Preis für 2500

Vermögenswert B

Marktkapitalisierung von B

Ergebnisse

$11,805.40 $57.55M